• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

PNPLA3 I148M(rs738409)基因变异与高危饮酒起始年龄是酒精性肝硬化的独立危险因素。

PNPLA3 I148M (rs738409) genetic variant and age at onset of at-risk alcohol consumption are independent risk factors for alcoholic cirrhosis.

作者信息

Burza Maria Antonella, Molinaro Antonio, Attilia Maria Luisa, Rotondo Claudia, Attilia Fabio, Ceccanti Mauro, Ferri Flaminia, Maldarelli Federica, Maffongelli Angela, De Santis Adriano, Attili Adolfo Francesco, Romeo Stefano, Ginanni Corradini Stefano

机构信息

Institute of Medicine, Department of Molecular and Clinical Medicine, Wallenberg Laboratory, University of Gothenburg, Gothenburg, Sweden.

出版信息

Liver Int. 2014 Apr;34(4):514-20. doi: 10.1111/liv.12310. Epub 2013 Sep 19.

DOI:10.1111/liv.12310
PMID:24102786
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4265268/
Abstract

BACKGROUND & AIMS: Environmental and genetic factors contribute to alcoholic cirrhosis onset. In particular, age at exposure to liver stressors has been shown to be important in progression to fibrosis in hepatitis C individuals. However, no definite data on the role of age at onset of at-risk alcohol consumption are available. Moreover, patatin-like phospholipase domain-containing protein 3 (PNPLA3) I148M (rs738409) variant has been associated with alcoholic cirrhosis, but only in cross-sectional studies. The aim of this study was to investigate the role of age at onset of at-risk alcohol consumption and PNPLA3 I148M variant on alcoholic cirrhosis incidence.

METHODS

A total of 384 at-risk alcohol drinkers were retrospectively examined. The association among age at onset of at-risk alcohol consumption, PNPLA3 I148M variant and cirrhosis incidence was tested.

RESULTS

A higher incidence of alcoholic cirrhosis was observed in individuals with an older (≥24 years) compared with a younger (<24) age at onset of at-risk alcohol consumption (P-value < 0.001). Moreover, PNPLA3 148M allele carriers showed an increased incidence of cirrhosis (P-value < 0.001). Both age at onset of at-risk alcohol consumption and PNPLA3 148M allele were independent risk factors for developing cirrhosis (H.R. (95% C.I.): 2.76 (2.18-3.50), P-value < 0.001; 1.53(1.07-2.19), P-value = 0.021 respectively). The 148M allele was associated with a two-fold increased risk of cirrhosis in individuals with a younger compared with an older age at onset of at-risk alcohol consumption (H.R. (95% C.I.): 3.03(1.53-6.00) vs. 1.61(1.09-2.38).

CONCLUSIONS

Age at onset of at-risk alcohol consumption and PNPLA3 I148M genetic variant are independently associated with alcoholic cirrhosis incidence.

摘要

背景与目的

环境和遗传因素促使酒精性肝硬化发病。尤其是,丙型肝炎患者接触肝脏应激源时的年龄在纤维化进展过程中已被证明很重要。然而,关于有风险饮酒起始年龄的作用尚无确切数据。此外,含帕他汀样磷脂酶结构域蛋白3(PNPLA3)I148M(rs738409)变异与酒精性肝硬化相关,但仅在横断面研究中。本研究旨在探讨有风险饮酒起始年龄和PNPLA3 I148M变异对酒精性肝硬化发病率的作用。

方法

对384名有风险饮酒者进行回顾性检查。检测有风险饮酒起始年龄、PNPLA3 I148M变异与肝硬化发病率之间的关联。

结果

与有风险饮酒起始年龄较小(<24岁)的个体相比,年龄较大(≥24岁)的个体酒精性肝硬化发病率更高(P值<0.001)。此外,PNPLA3 148M等位基因携带者肝硬化发病率增加(P值<0.001)。有风险饮酒起始年龄和PNPLA3 148M等位基因均为发生肝硬化的独立危险因素(风险比(95%置信区间):分别为2.76(2.18 - 3.50),P值<0.001;1.53(1.07 - 2.19),P值 = 0.021)。与有风险饮酒起始年龄较大的个体相比,148M等位基因与有风险饮酒起始年龄较小的个体患肝硬化风险增加两倍相关(风险比(95%置信区间):3.03(1.53 - 6.00)对1.61(1.09 - 2.38))。

结论

有风险饮酒起始年龄和PNPLA3 I148M基因变异与酒精性肝硬化发病率独立相关。

相似文献

1
PNPLA3 I148M (rs738409) genetic variant and age at onset of at-risk alcohol consumption are independent risk factors for alcoholic cirrhosis.PNPLA3 I148M(rs738409)基因变异与高危饮酒起始年龄是酒精性肝硬化的独立危险因素。
Liver Int. 2014 Apr;34(4):514-20. doi: 10.1111/liv.12310. Epub 2013 Sep 19.
2
Patatin-like phospholipase domain containing-3 gene I148M polymorphism, steatosis, and liver damage in hereditary hemochromatosis.载脂蛋白样磷脂酶结构域蛋白 3 基因 I148M 多态性与遗传性血色素沉着症中的脂肪变性和肝损伤。
World J Gastroenterol. 2012 Jun 14;18(22):2813-20. doi: 10.3748/wjg.v18.i22.2813.
3
The PNPLA3 rs738409 148M/M genotype is a risk factor for liver cancer in alcoholic cirrhosis but shows no or weak association in hepatitis C cirrhosis.载脂蛋白 L3(PNPLA3)rs738409 148M/M 基因型是酒精性肝硬化肝癌的危险因素,但在丙型肝炎肝硬化中无关联或关联较弱。
PLoS One. 2011;6(11):e27087. doi: 10.1371/journal.pone.0027087. Epub 2011 Nov 7.
4
Synergistic Associations of PNPLA3 I148M Variant, Alcohol Intake, and Obesity With Risk of Cirrhosis, Hepatocellular Carcinoma, and Mortality.载脂蛋白基因 PNPLA3 I148M 变异、饮酒和肥胖与肝硬化、肝细胞癌和死亡风险的协同关联。
JAMA Netw Open. 2022 Oct 3;5(10):e2234221. doi: 10.1001/jamanetworkopen.2022.34221.
5
PNPLA3 rs738409 associates with alcoholic liver cirrhosis but not with serum levels of IL6, IL10, IL8 or CCL2 in the Russian population.在俄罗斯人群中,PNPLA3 rs738409 与酒精性肝硬化相关,但与血清中 IL6、IL10、IL8 或 CCL2 的水平无关。
Ann Hepatol. 2021 Jan-Feb;20:100247. doi: 10.1016/j.aohep.2020.08.065. Epub 2020 Aug 29.
6
PNPLA3 I148M (rs738409) genetic variant is associated with hepatocellular carcinoma in obese individuals.载脂蛋白 L3 基因 I148M(rs738409) 遗传变异与肥胖个体的肝细胞癌有关。
Dig Liver Dis. 2012 Dec;44(12):1037-41. doi: 10.1016/j.dld.2012.05.006. Epub 2012 Jun 15.
7
PNPLA3 I148M polymorphism and progressive liver disease.PNPLA3 I148M 多态性与进行性肝病。
World J Gastroenterol. 2013 Nov 7;19(41):6969-78. doi: 10.3748/wjg.v19.i41.6969.
8
Interaction between PNPLA3 I148M variant and age at infection in determining fibrosis progression in chronic hepatitis C.在慢性丙型肝炎中,PNPLA3 I148M变异体与感染年龄之间的相互作用对纤维化进展的影响
PLoS One. 2014 Aug 29;9(8):e106022. doi: 10.1371/journal.pone.0106022. eCollection 2014.
9
Patatin-like phospholipase domain-containing 3 I148M affects liver steatosis in patients with chronic hepatitis B.载脂蛋白样磷脂酶结构域蛋白 3 I148M 影响慢性乙型肝炎患者的肝脏脂肪变性。
Hepatology. 2013 Oct;58(4):1245-52. doi: 10.1002/hep.26445. Epub 2013 Aug 6.
10
Patatin-like phospholipase domain-containing 3 (PNPLA3) I148M (rs738409) affects hepatic VLDL secretion in humans and in vitro.载脂蛋白样磷脂酶结构域蛋白 3(PNPLA3)I148M(rs738409)影响人类和体外的肝脏 VLDL 分泌。
J Hepatol. 2012 Dec;57(6):1276-82. doi: 10.1016/j.jhep.2012.07.030. Epub 2012 Aug 6.

引用本文的文献

1
Non-alcoholic fatty liver disease: Role of PNPLA3 and its association with environmental chemicals.非酒精性脂肪性肝病:PNPLA3的作用及其与环境化学物质的关联
Arch Clin Toxicol (Middlet). 2024;6(1):21-32. doi: 10.46439/toxicology.6.029.
2
Meta-Analysis: Effects of Steatotic Liver Disease-Associated Genetic Risk Alleles on Longitudinal Outcomes.荟萃分析:脂肪性肝病相关基因风险等位基因对纵向结局的影响。
Aliment Pharmacol Ther. 2025 Aug;62(3):244-276. doi: 10.1111/apt.70256. Epub 2025 Jun 28.
3
Advances in the management of alcohol-associated liver disease.

本文引用的文献

1
Patatin-like phospholipase domain containing-3 gene I148M polymorphism, steatosis, and liver damage in hereditary hemochromatosis.载脂蛋白样磷脂酶结构域蛋白 3 基因 I148M 多态性与遗传性血色素沉着症中的脂肪变性和肝损伤。
World J Gastroenterol. 2012 Jun 14;18(22):2813-20. doi: 10.3748/wjg.v18.i22.2813.
2
PNPLA3 I148M (rs738409) genetic variant is associated with hepatocellular carcinoma in obese individuals.载脂蛋白 L3 基因 I148M(rs738409) 遗传变异与肥胖个体的肝细胞癌有关。
Dig Liver Dis. 2012 Dec;44(12):1037-41. doi: 10.1016/j.dld.2012.05.006. Epub 2012 Jun 15.
3
EASL clinical practical guidelines: management of alcoholic liver disease.
酒精性肝病管理的进展
Gastroenterol Rep (Oxf). 2024 Nov 5;12:goae097. doi: 10.1093/gastro/goae097. eCollection 2024.
4
PNPLA3 rs738409, age, diabetes, sex, and advanced fibrosis jointly contribute to the risk of major adverse liver outcomes in metabolic dysfunction-associated steatotic liver disease.载脂蛋白 L3(rs738409)、年龄、糖尿病、性别和肝纤维化程度共同导致代谢相关脂肪性肝病伴显著肝纤维化患者发生主要不良肝脏结局的风险增加。
Hepatology. 2024 Nov 1;80(5):1212-1226. doi: 10.1097/HEP.0000000000000896. Epub 2024 Apr 23.
5
Effect of donor genotype on patient survival after liver transplant: a retrospective cohort study.供体基因型对肝移植术后患者生存的影响:一项回顾性队列研究。
EClinicalMedicine. 2023 Dec 13;67:102350. doi: 10.1016/j.eclinm.2023.102350. eCollection 2024 Jan.
6
New Diagnostic and Prognostic Models for the Development of Alcoholic Cirrhosis Based on Genetic Predisposition and Alcohol History.基于遗传易感性和饮酒史的酒精性肝硬化发展的新诊断和预后模型
Biomedicines. 2023 Jul 28;11(8):2132. doi: 10.3390/biomedicines11082132.
7
Genetic variant rs72613567 of HSD17B13 gene reduces alcohol-related liver disease risk in Chinese Han population.HSD17B13 基因上的遗传变异 rs72613567 降低了中国汉族人群的酒精性肝病风险。
Liver Int. 2020 Sep;40(9):2194-2202. doi: 10.1111/liv.14616. Epub 2020 Aug 3.
8
Omics-derived hepatocellular carcinoma risk biomarkers for precision care of chronic liver diseases.基于组学的肝细胞癌风险生物标志物用于慢性肝病的精准治疗。
Hepatol Res. 2020 Jul;50(7):817-830. doi: 10.1111/hepr.13506. Epub 2020 May 15.
9
PNPLA3-A Potential Therapeutic Target for Personalized Treatment of Chronic Liver Disease.PNPLA3——慢性肝病个性化治疗的潜在治疗靶点。
Front Med (Lausanne). 2019 Dec 17;6:304. doi: 10.3389/fmed.2019.00304. eCollection 2019.
10
Hepatocellular Carcinoma Risk Stratification by Genetic Profiling in Patients with Cirrhosis.肝硬化患者的基因谱分析进行肝细胞癌风险分层。
Semin Liver Dis. 2019 May;39(2):153-162. doi: 10.1055/s-0039-1681031. Epub 2019 Mar 25.
欧洲肝脏研究学会临床实践指南:酒精性肝病的管理
J Hepatol. 2012 Aug;57(2):399-420. doi: 10.1016/j.jhep.2012.04.004. Epub 2012 May 26.
4
Evolution of indications and results of liver transplantation in Europe. A report from the European Liver Transplant Registry (ELTR).欧洲肝移植的适应证演变与结果。欧洲肝移植登记处(ELTR)的报告。
J Hepatol. 2012 Sep;57(3):675-88. doi: 10.1016/j.jhep.2012.04.015. Epub 2012 May 16.
5
IL28B and PNPLA3 polymorphisms affect histological liver damage in patients with non-alcoholic fatty liver disease.IL28B 和 PNPLA3 多态性影响非酒精性脂肪性肝病患者的肝组织学损伤。
J Hepatol. 2012 Jun;56(6):1356-62. doi: 10.1016/j.jhep.2012.01.007. Epub 2012 Feb 5.
6
PNPLA3 (rs738409 C>G) is a common risk variant associated with hepatocellular carcinoma in alcoholic cirrhosis.PNPLA3(rs738409 C>G)是一种与酒精性肝硬化中的肝细胞癌相关的常见风险变异体。
Hepatology. 2012 Apr;55(4):1307-8. doi: 10.1002/hep.25518.
7
Genetic determinants of alcoholic liver disease.酒精性肝病的遗传决定因素。
Gut. 2012 Jan;61(1):150-9. doi: 10.1136/gutjnl-2011-301239. Epub 2011 Nov 22.
8
The PNPLA3 rs738409 148M/M genotype is a risk factor for liver cancer in alcoholic cirrhosis but shows no or weak association in hepatitis C cirrhosis.载脂蛋白 L3(PNPLA3)rs738409 148M/M 基因型是酒精性肝硬化肝癌的危险因素,但在丙型肝炎肝硬化中无关联或关联较弱。
PLoS One. 2011;6(11):e27087. doi: 10.1371/journal.pone.0027087. Epub 2011 Nov 7.
9
PNPLA3 rs738409C/G polymorphism in cirrhosis: relationship with the aetiology of liver disease and hepatocellular carcinoma occurrence.载脂蛋白基因 PNPLA3 rs738409C/G 多态性与肝硬化:与肝病病因及肝细胞癌发生的关系。
Liver Int. 2011 Sep;31(8):1137-43. doi: 10.1111/j.1478-3231.2011.02534.x. Epub 2011 Apr 19.
10
Genetic variation in the interleukin-28B gene is not associated with fibrosis progression in patients with chronic hepatitis C and known date of infection.白细胞介素-28B 基因的遗传变异与已知感染日期的慢性丙型肝炎患者的纤维化进展无关。
Hepatology. 2011 Oct;54(4):1127-34. doi: 10.1002/hep.24503. Epub 2011 Aug 19.